Filing Details
CYTOKINETICS INC (NASDAQ:CYTK) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
8k filedNASDAQ:CYTK
CYTOKINETICS INC (CYTK) Reports Material Event to SEC
CYTOKINETICS INC (NASDAQ:CYTK) filed a Form 8-K with the Securities and Exchange Commission on August 13, 2026, disclosing a material event.
At publication ·
What changed
CYTOKINETICS INC (NASDAQ:CYTK) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Cytokinetics Inc filed a Form 8-K with the SEC on August 13, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this article.
- The company's stock trades at $73.45 with a market capitalization of $7.2 billion as of the filing date.
- Form 8-K filings report material events such as leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance that occur between regular quarterly or annual reports.
Market Context
CYTOKINETICS INC's stock currently trades at $73.45 with a market capitalization of $7.2B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CYTOKINETICS INC's stock.
All SEC filings for CYTOKINETICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CYTK Stock Page
Frequently Asked Questions
Where can I read CYTK's SEC filings?
Browse all filings on our CYTK SEC filings page.
What types of SEC filings does CYTOKINETICS INC file?
Public companies like CYTOKINETICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.